B. Metzler Seel. Sohn & Co. Ag Bio N Tech Se Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $9.53 Billion
- Q4 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Bio N Tech Se stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 11,959 shares of BNTX stock, worth $1.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,959
Previous 9,468
26.31%
Holding current value
$1.4 Million
Previous $1.12 Million
21.17%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$962 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$516 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$503 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$222 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$211 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...